SH3BP5L
SH3 domain-binding protein 5-like
Also known as: 3BP5L_HUMAN, KIAA1720
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L8J4
- Gene
- SH3BP5L
- Ensembl
- ENSG00000175137
- Chromosome
- 1
- Canonical length
- 393 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Vesicles
OverviewNCBI Gene
Enables guanyl-nucleotide exchange factor activity. Predicted to be involved in intracellular signal transduction. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
393 residues, UniProt reviewed canonical sequence.
>Q7L8J4|SH3BP5L
1 MAELRQVPGG RETPQGELRP EVVEDEVPRS PVAEEPGGGG SSSSEAKLSP REEEELDPRI
61 QEELEHLNQA SEEINQVELQ LDEARTTYRR ILQESARKLN TQGSHLGSCI EKARPYYEAR
121 RLAKEAQQET QKAALRYERA VSMHNAAREM VFVAEQGVMA DKNRLDPTWQ EMLNHATCKV
181 NEAEEERLRG EREHQRVTRL CQQAEARVQA LQKTLRRAIG KSRPYFELKA QFSQILEEHK
241 AKVTELEQQV AQAKTRYSVA LRNLEQISEQ IHARRRGGLP PHPLGPRRSS PVGAEAGPED
301 MEDGDSGIEG AEGAGLEEGS SLGPGPAPDT DTLSLLSLRT VASDLQKCDS VEHLRGLSDH
361 VSLDGQELGT RSGGRRGSDG GARGGRHQRS VSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SH3BP5L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 29 nTPM
- cerebellum: 27 nTPM
- cerebral cortex: 24 nTPM
- esophagus: 22 nTPM
- heart muscle: 20 nTPM
- skin: 18 nTPM
Single-cell type
- esophageal apical cells: 53 nCPM
- neutrophils: 34 nCPM
- platelets: 24 nCPM
- neutrophil progenitors: 20 nCPM
- retinal pigment epithelial cells: 17 nCPM
- adrenal cortex cells: 16 nCPM
Immune cell
- basophil: 7.7 nTPM
- neutrophil: 4.7 nTPM
- eosinophil: 4.1 nTPM
- classical monocyte: 1.2 nTPM
- myeloid DC: 1.1 nTPM
- memory CD4 T-cell: 1 nTPM
Brain region
- cerebral cortex: 27 nTPM
- white matter: 23 nTPM
- hippocampal formation: 22 nTPM
- amygdala: 22 nTPM
- basal ganglia: 21 nTPM
- cerebellum: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- -0.32
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SH3BP5L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SH3BP5L as an antibody target. Whether an autoantibody or antibody against SH3BP5L could matter depends on whether native SH3BP5L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SH3BP5L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SH3BP5L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...